Given the important role of KP (Fig. 1) in immunosuppression and tumor growth, we screened BrCa models for the first rate-limiting enzyme of the KP, IDO1, which is known to play a significant role in modulating immune response using the publicly available, large population-based METABRIC BrCa dataset. This evidence concerns the gene NPPA and invasive breast carcinoma.